Copyright
©The Author(s) 2021.
World J Gastroenterol. Nov 14, 2021; 27(42): 7324-7339
Published online Nov 14, 2021. doi: 10.3748/wjg.v27.i42.7324
Published online Nov 14, 2021. doi: 10.3748/wjg.v27.i42.7324
Figure 6 Prion protein expression.
Comparisons between two groups were made by using Student t-test. Values are given as the mean ± SD. A: Prion protein expression according to the presence of disease recurrence after surgery. The histogram compares the expression of prion protein with western blot in specimen from patients surgically resected for pancreatic ductal adenocarcinoma with no evidence of disease at 12-mo follow-up (n = 11) with those from patients with disease recurrence (n = 13). aP = 0.023. B: Prion protein expression according to the presence of disease recurrence after surgery in patients treated with adjuvant chemotherapy. The histogram compares the expression of prion protein with western blot in specimen from patients surgically resected for pancreatic ductal adenocarcinoma with no evidence of disease at 12 mo and treated with adjuvant chemotherapy (CT) (n = 10) with those from patients treated with adjuvant CT with disease recurrence (n = 11). aP = 0.028.
- Citation: Bianchini M, Giambelluca MA, Scavuzzo MC, Di Franco G, Guadagni S, Palmeri M, Furbetta N, Gianardi D, Funel N, Ricci C, Gaeta R, Pollina LE, Falcone A, Vivaldi C, Di Candio G, Biagioni F, Busceti CL, Morelli L, Fornai F. Detailing the ultrastructure’s increase of prion protein in pancreatic adenocarcinoma. World J Gastroenterol 2021; 27(42): 7324-7339
- URL: https://www.wjgnet.com/1007-9327/full/v27/i42/7324.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i42.7324